Chemours
377 hedge funds and large institutions have $2.19B invested in Chemours in 2016 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 87 increasing their positions, 134 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% more funds holding
Funds holding: 371 → 377 (+6)
1.76% less ownership
Funds ownership: 77.86% → 76.1% (-1.8%)
35% less repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 134
Holders
377
Holding in Top 10
10
Calls
$32.8M
Puts
$18.8M
Top Buyers
| 1 | +$48.8M | |
| 2 | +$23.8M | |
| 3 | +$20.6M | |
| 4 |
SCM
Schneider Capital Management
Berwyn,
Pennsylvania
|
+$18.4M |
| 5 |
MRCP
Maple Rock Capital Partners
Toronto,
Ontario, Canada
|
+$15.2M |
Top Sellers
| 1 | -$42.2M | |
| 2 | -$39.1M | |
| 3 | -$21.1M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$17.7M |
| 5 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$16M |